MedTrace Logo

Taurine in Peripartum Cardiomyopathy

NCT03907267 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2020-01-28

No results posted yet for this study

Summary

Taurine as an adjunct for early left ventricular recovery in peripartum cardiomyopathy

Conditions

  • Peripartum Cardiomyopathy

Interventions

DRUG

Taurine Solution

Taurine Solution

DIETARY_SUPPLEMENT

Normal Saline

Normal Saline

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-01
Primary Completion
2019-12-01
Completion
2020-01-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03907267 on ClinicalTrials.gov